Clinical Trial Update: Venetoclax Combining With Fludarabine and Melphalan as Conditioning Regimen for Allo-HSCT [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating venetoclax with fludarabine and melphalan as a conditioning regimen for allogeneic hematopoietic stem cell transplantation in hematolog…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Malignancy

Drugs mentioned

• venetoclax with fludarabine and melphalan conditioning regimen

Snippet

Sponsor: First Affiliated Hospital of Zhejiang University | Conditions: Hematologic Malignancy, Older Patients | Phase 2 | Status: UNKNOWN